Ardent Health Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Ardent Health Inc (ARDT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Ardent Health Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 6,406M vs 163,983M combined for its competitors (3.8% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (+1.3% annualized vs trailing 12 months), vs holding steady (+1.8%) for its tracked peer group.
- Growth: Ardent Health Inc generated -1.4% revenue growth year over year in Q2 2026, vs 6.4% for its competitors combined.
- Profitability: Its 2.1% net margin compares with 9.4% for the peer group.
- Scale: Ardent Health Inc ranks #21 of 51 companies by market capitalization in the Healthcare Facilities industry, holding 0.9% of industry market cap.
- Peer revenue share: Ardent Health Inc accounted for 3.7% of combined revenue among its tracked peer group, down from 4.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.25M compares with $0.22M for the peer group (1.1x).
- Structure: Ardent Health Inc operates in the following segments: Reportable.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
ARDT Sales vs. its Competitors, Q2 2026
Ardent Health Inc reported revenue contraction of 1.40 % year on year in Q2 2026, below its competitors' combined revenue growth of 6.35 %.
With a net margin of 2.14 %, Ardent Health Inc reported lower profitability than its competitors (9.40 %).
Ardent Health Inc generated 3.74 % of the combined sales of its peer group, down from 4.02 % a year earlier.
API endpoints for this dataset
Ardent Health Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Ardent Health Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Ardent Health Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Ardent Health Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (1) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (10) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (4) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Ardent Health Inc's competitor groups requires a Commercial License.
For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs -1.4% for Ardent Health Inc. Ardent Health Inc's share of combined industry revenue moved from 1.58% to 1.36%, a loss of 0.22 percentage points.
Ardent Health Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Ardent Health Inc | Yes | Yes | No | No |
| Competitors combined (15) | ||||
| High-Confidence Competitors (1) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 100.00 % (7 of 7) | 75.00 % (6 of 8) | 50.00 % (4 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
ARDT Stock Performance relative to its Competitors
ARDT Stock Performance relative to High-Confidence Competitors
ARDT Stock Performance relative to Similar-Size Competitors
ARDT Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Acadia Healthcare Company Inc | 282.9% | Outperformed |
| 2 | National Healthcare Corp | 282.9% | Outperformed |
| 3 | Davita Inc | 282.9% | Outperformed |
| 4 | Aveanna Healthcare Holdings Inc | 282.9% | Outperformed |
| 5 | Pediatrix Medical Group Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Ardent Health Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Ardent Health Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Ardent Health Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Ardent Health Inc |
2,474.81 | 6,405.94 |
 Hca Healthcare Inc |
107,517.77 | 78,701.00 |
 Tenet Healthcare Corp |
22,836.40 | 22,154.00 |
 Encompass Health Corporation |
13,712.74 | 6,338.10 |
 Davita Inc |
12,534.19 | 14,167.55 |
 Universal Health Services Inc |
11,712.40 | 18,114.49 |
| SUBTOTAL | 195,059.46 | 198,152.07 |
Sign in to see all competitors of Ardent Health Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Ardent Health Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Ardent Health Inc's Competitors Named by the Company
Competitive relationships identified from Ardent Health Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| EGI-AM | Company report | 85% |
| Ventas | Company report | 85% |
| Pediatrix Medical Group Inc | Company report | 85% |
| Tenet Healthcare Corp | Company report | 85% |
| Acadia Healthcare Company Inc | Company report | 85% |
| Community Health Systems Inc | Company report | 85% |
| National Healthcare Corp | Company report | 85% |
| Hca Healthcare Inc | Company report | 85% |
| Ethema Health Corporation | Company report | 85% |
| Universal Health Services Inc | Company report | 85% |
| Surgery Partners Inc | Company report | 85% |
| Select Medical Holdings Corp | Company report | 85% |
| Encompass Health Corporation | Company report | 85% |
Company report basis, confidence, active dates and source counts for Ardent Health Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Ardent Health Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Ardent Health Inc | Reportable 100.00 % |
| Hca Healthcare Inc | American Group 34.50 % |
| Tenet Healthcare Corp | Hospital Operations 75.65 % |
| Encompass Health Corporation | Inpatient Rehabilitation 100.00 % |
| Davita Inc | U. S. Dialysis And Related Lab Services 84.64 % |
| Universal Health Services Inc | Acute Care Hospital Services 58.40 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Ardent Health Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Ardent Health Inc | 2,475 | 254,204 | 6,692 |
| Hca Healthcare Inc | 107,518 | 245,941 | 22,806 |
| Tenet Healthcare Corp | 22,836 | 223,778 | 38,525 |
| Encompass Health Corporation | 13,713 | 150,907 | 19,252 |
| Davita Inc | 12,534 | 181,635 | 15,028 |
| Universal Health Services Inc | 11,712 | 178,468 | 15,273 |
| PEERS TOTAL | 192,585 | 221,824 | 18,362 |
Sign in to see all peers for Ardent Health Inc .
Ardent Health Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 48 companies in Ardent Health Inc's industry classification, broader than the peer set above. Market cap in millions of $.Ardent Health Inc ranks #21 of 48 companies by market capitalization in its industry, holding 0.90 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,834, indicating a moderately concentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Hca Healthcare Inc | 110,298 | 40.05 % |
| 2 | Tenet Healthcare Corp | 23,790 | 8.64 % |
| 3 | Brightspring Health Services Inc | 14,792 | 5.37 % |
| 4 | Encompass Health Corporation | 13,754 | 4.99 % |
| 5 | Davita Inc | 1,234 | 5.2% |
| 6 | Universal Health Services Inc | 1,234 | 5.2% |
| 7 | Ensign Group Inc | 1,234 | 5.2% |
| 8 | Pacs Group Inc | 1,234 | 5.2% |
| 9 | Chemed Corporation | 1,234 | 5.2% |
| 10 | Fresenius Medical Care Ag | 1,234 | 5.2% |
| 21 | Ardent Health Inc | 2,475 | 0.90 % |
Market cap and industry share for the rest of Ardent Health Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-06.
Ardent Health Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 16 | National Healthcare Corp | 3,313 | 62.67 % |
| 17 | Surgery Partners Inc | 2,989 | 5.51 % |
| 18 | Aveanna Healthcare Holdings Inc | 2,979 | 45.87 % |
| 19 | Progyny Inc | 2,862 | 81.41 % |
| 20 | Pediatrix Medical Group Inc | 1,234 | 12.3% |
| 21 | Ardent Health Inc | 2,475 | 6.78 % |
| 22 | Addus Homecare Corp | 1,234 | 12.3% |
| 23 | Brookdale Senior Living Inc | 1,234 | 12.3% |
| 24 | Agilon Health Inc | 1,234 | 12.3% |
| 25 | Healthcare Services Group Inc | 1,234 | 12.3% |
| 26 | Teladoc Health Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Ardent Health Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-06. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Ardent Health Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Healthcare Facilities industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (113 companies). See the full Healthcare Facilities industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 0.00 % | 34.25 % (avg) | -34.2 pp |
| Operating Margin | 29.30 % | industry median | +21.7 pp |
| EBITDA Margin | 5.87 % | 2.94 % (avg) | +2.9 pp |
| Capital Intensity (Capex / Revenue) | 3.27 % | 3.80 % (avg) | -0.5 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Ardent Health Inc's Valuation vs Competitive Position
Valuation multiples vs the Healthcare Facilities industry average (113 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Healthcare Facilities industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 17.2x | 21.2x | -4.0x |
| EV / EBITDA | 5.5x | 13.9x | -8.4x |
| P/B | 0.8x | 3.1x | -2.3x |
| Return on Equity | 9.92 % | industry aggregate | -32.56 % |
| Return on Invested Capital | 30.22 % | 1.98 % (avg) | 28.24 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Ardent Health Inc's Strategic Group Map
Ardent Health Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Ardent Health Inc's trailing-12-month revenue growth of 3.3% and operating margin of 29.3% compares with an average of 3.3% growth and 20.5% margin across its 8 closest peers by combined growth, margin and ROIC -- Ardent Health Inc sits below that peer average on growth and above it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Ardent Health Inc's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
Ardent Health Inc falls in the Dog quadrant: relative market share of 0.02x vs its largest competitor, in an industry growing revenue 5.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Hca Healthcare Inc alone holds 40% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Ardent Health Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,834 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Moderate, in line with the industry | Capital intensity (capex / revenue) of 3.27 % vs industry average 3.80 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Ardent Health Inc's dedicated Suppliers and Customers pages, not here.
Ardent Health Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Ardent Health Inc falls in the Medium attractiveness / Medium strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Ardent Health Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 21.7 points above the industry median.
Weaknesses
- Return on equity 32.6 points below the industry aggregate.
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.02x).
Opportunities
- Trades at a lower P/E than the industry average (17.2x vs 21.2x) despite a higher return on invested capital -- a possible re-rating opportunity.
Threats
- Industry dominated by Hca Healthcare Inc , holding 40.05 % of industry market cap.
Methodology: see Methodology: SWOT Analysis.
Ardent Health Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Ardent Health Inc | 0.68 | 2.07 | 0.81 |
| Hca Healthcare Inc | 0.05 | 0.90 | - |
| Tenet Healthcare Corp | 0.50 | 1.51 | 3.47 |
| Encompass Health Corporation | 0.10 | 1.14 | 1.16 |
| Davita Inc | 0.21 | 1.39 | - |
| Universal Health Services Inc | 0.04 | 1.07 | 0.72 |
Sign in to see all peers for Ardent Health Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Ardent Health Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Ardent Health Inc | Q2 2026 | -1.4 % | -63.8 % |
| Hca Healthcare Inc | Q3 2026 | +3.6 % | -17.0 % |
| Tenet Healthcare Corp | Q3 2026 | +6.5 % | +110.5 % |
| Encompass Health Corporation | Q3 2026 | +8.9 % | -14.1 % |
| Davita Inc | Q3 2026 | +4.6 % | -7.2 % |
| Universal Health Services Inc | Q2 2026 | +8.3 % | +0.5 % |
| PEERS TOTAL | +4.4 % | +9.9 % |
Sign in to see all peers for Ardent Health Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Ardent Health Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Ardent Health Inc | Q2 2026 | - | -16.3 % |
| Hca Healthcare Inc | Q3 2026 | - | +5.4 % |
| Tenet Healthcare Corp | Q3 2026 | +25.7 % | -29.3 % |
| Encompass Health Corporation | Q3 2026 | - | +25.3 % |
| Davita Inc | Q3 2026 | - | -4.0 % |
| Universal Health Services Inc | Q2 2026 | - | -14.4 % |
Sign in to see all peers for Ardent Health Inc .
Ardent Health Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Ardent Health Inc | 3.22% | 3.74% | 9.92% |
| Hca Healthcare Inc | 11.73% | 15.54% | - |
| Tenet Healthcare Corp | 12.39% | 10.91% | 57.13% |
| Encompass Health Corporation | 10.99% | 10.41% | 24.08% |
| Davita Inc | 6.65% | 6.13% | - |
| Universal Health Services Inc | 9.92% | 12.43% | 20.89% |
Sign in to see all peers for Ardent Health Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Ardent Health Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Ardent Health Inc | 31.45 | 0.39 |
| Hca Healthcare Inc | 17.25 | 1.37 |
| Tenet Healthcare Corp | 8.25 | 1.03 |
| Encompass Health Corporation | 21.50 | 2.16 |
| Davita Inc | 15.81 | 0.88 |
| Universal Health Services Inc | 8.01 | 0.65 |
| PEERS AVERAGE | 12.16 | 0.98 |
Sign in to see all peers for Ardent Health Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.